---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-023189"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:44:29.047680+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Elutia regains full compliance with Nasdaq minimum bid price and MVLS requirements

## Summary
- Received Nasdaq notice on March 2, 2026, confirming compliance with minimum bid price rule (bid ≥ $1.00 for 10 consecutive days).
- Received Nasdaq notice on February 5, 2026, confirming compliance with MVLS requirement (MVLS ≥ $35M for 11 consecutive days).
- All Nasdaq continued listing requirements are now met; matters are closed; stock continues trading on Nasdaq Capital Market under symbol ELUT.
- CFO Matt Ferguson cites investor confidence in drug-eluting biomatrix technology platform and market opportunity.

## SEC filing metadata
- accession: 0001104659-26-023189
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000110465926023189/0001104659-26-023189-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000110465926023189/elut-20260304x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-023189
- JSON: https://secwatch.observer/filing/0001104659-26-023189.json
- Plain text: https://secwatch.observer/filing/0001104659-26-023189.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.